HU0202757A3
Untitled record
Abstract
Compound of formula (II) wherein X, Y, and Z are independently selected from the group consisting of N, O, S, C, and CO wherein at least one of X, Y, and Z is a heteroatom; Ar<1> and Ar<2> are independently selected from the group consisting of a heterocyclic or fused heterocyclic moiety and an aromatic moiety; act as antagonist at metabotropic glutamate receptors, and are useful for treating neurological diseases and disorders.
Term
No projected expiry on record.
- Priority
- Filed
- Published
- Today
87 members in 31 offices
Priority claims2
| Document | Office | Kind | Date |
|---|---|---|---|
| 14946499 | United States of America | P | |
| 0022618 | United States of America | W |
Members87
| Document | Office | Kind | |
|---|---|---|---|
| CA2381975A1 | Canada | A1 | |
| WO0112627A1 | World Intellectual Property Organization (WIPO) | A1 | |
| AU6782400A | Australia | A | |
| IS6275A | Iceland | A | |
| NO20020823D0 | Norway | D0 | |
| NO20020823L | Norway | L | |
| KR20020038731A | Republic of Korea | A | |
| EP1210344A1 | European Patent Office (EPO) | A1 | |
| CZ2002599A3 | Czechia | A3 | |
| SK2512002A3 | Slovakia | A3 | |
| BR0013427A | Brazil | A | |
| CA2438991A1 | Canada | A1 | |
| WO02068417A2 | World Intellectual Property Organization (WIPO) | A2 | |
| IL148157D0 | Israel | D0 | |
| CN1379775A | China | A | |
| WO02068417A3 | World Intellectual Property Organization (WIPO) | A3 | |
| HU0202757A2 | Hungary | A2 | |
| BG106493A | Bulgaria | A | |
| JP2003507378A | Japan | A | |
| HK1047929A1 | Hong Kong, China | A1 | |
| US2003055085A1 | United States of America | A1 | |
| EE200200079A | Estonia | A | |
| ZA200201358B | South Africa | B | |
| IS6922A | Iceland | A | |
| NO20033711D0 | Norway | D0 | |
| NO20033711L | Norway | L | |
| KR20030088434A | Republic of Korea | A | |
| PL353825A1 | Poland | A1 | |
| US6660753B2 | United States of America | B2 | |
| EP1379525A2 | European Patent Office (EPO) | A2 | |
| NZ517221A | New Zealand | A | |
| MXPA02001764A | Mexico | A | |
| IL157491D0 | Israel | D0 | |
| MXPA03007513A | Mexico | A | |
| HK1060559A1 | Hong Kong, China | A1 | |
| BR0207390A | Brazil | A | |
| ZA200306493B | South Africa | B | |
| JP2004536037A | Japan | A | |
| AU780191B2 | Australia | B2 | |
| RU2003128535A | Russian Federation | A | |
| PL369598A1 | Poland | A1 | |
| US2005154027A1 | United States of America | A1 | |
| CN1649865A | China | A | |
| EP1582519A2 | European Patent Office (EPO) | A2 | |
| EP1210344B1 | European Patent Office (EPO) | B1 | |
| AT307129T | Austria | T | |
| UA74419C2 | Ukraine | C2 | |
| EP1582519A3 | European Patent Office (EPO) | A3 | |
| DE60023318D1 | Germany | D1 | |
| DK1210344T3 | Denmark | T3 | |
| HU0202757A3This record | Hungary | A3 | |
| ES2250177T3 | Spain | T3 | |
| JP2006143746A | Japan | A | |
| UA75871C2 | Ukraine | C2 | |
| JP3790472B2 | Japan | B2 | |
| EP1679313A2 | European Patent Office (EPO) | A2 | |
| JP2006182789A | Japan | A | |
| DE60023318T2 | Germany | T2 | |
| EP1679313A3 | European Patent Office (EPO) | A3 | |
| US2006189661A1 | United States of America | A1 | |
| US7112595B2 | United States of America | B2 | |
| NO322460B1 | Norway | B1 | |
| CN1853630A | China | A | |
| NZ527691A | New Zealand | A | |
| RU2296127C2 | Russian Federation | C2 | |
| CN1313465C | China | C | |
| IL148157A | Israel | A | |
| CN1332959C | China | C | |
| RU2296127C9 | Russian Federation | C9 | |
| AU2002306517B2 | Australia | B2 | |
| EP1379525B1 | European Patent Office (EPO) | B1 | |
| AT375340T | Austria | T | |
| DE60222872D1 | Germany | D1 | |
| PT1379525E | Portugal | E | |
| DK1379525T3 | Denmark | T3 | |
| SI1379525T1 | Slovenia | T1 | |
| ES2292830T3 | Spain | T3 | |
| RU2319701C2 | Russian Federation | C2 | |
| KR100838447B1 | Republic of Korea | B1 | |
| DE60222872T2 | Germany | T2 | |
| NO326105B1 | Norway | B1 | |
| KR100875222B1 | Republic of Korea | B1 | |
| BG65586B1 | Bulgaria | B1 | |
| IS2564B | Iceland | B | |
| JP4519404B2 | Japan | B2 | |
| CA2438991C | Canada | C | |
| CY1107005T1 | Cyprus | T1 |
Numbers
- Application
- 202757
Titles
- English
- HETEROPOLYCYCLIC COMPOUNDS, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THEIR USE AS METABOTROPIC GLUTAMATE RECEPTOR ANTAGONISTS
Classification
- CPC, 17
- C07D401/04
- C07D413/04
- A61P25/00
- A61P25/04
- A61P25/06
- A61P25/08
- A61P25/14
- A61P25/16
- A61P25/18
- A61P25/24
- A61P25/28
- A61P29/00
- A61P29/02
- A61P3/08
- A61P43/00
- A61P9/00
- A61P9/10
- IPC, 19
- A61K
- A61K31 4245
- A61K31 4439
- A61K31 4709
- A61K31 4725
- A61K31 497
- A61P
- A61P9 10
- A61P25 00
- A61P25 06
- A61P25 08
- A61P25 14
- A61P25 16
- A61P25 28
- A61P29 00
- C07D
- C07D401 04
- C07D403 04
- C07D413 04